Stock-Based Compensation

9 Months Ended

Sep. 30, 2025

Share-Based Payment Arrangement [Abstract]

11. Stock-Based Compensation

The Company has stock-based compensation plans, which are more fully described in Note 11, Stock Plans, to the Consolidated Financial Statements included in the 2024 10-K. During the nine months ended September 30, 2025, the Company granted restricted stock units (“RSUs”) subject to service conditions, RSUs subject to service and performance conditions, and RSUs subject to service and market conditions.

Stock Options

The following table summarizes the activities for all stock options under the Company’s stock-based compensation plans for the nine months ended September 30, 2025:


	Number of Options Outstanding	Weighted-Average Exercise Price		Weighted-Average Remaining Contractual Term	Aggregate Intrinsic Value(1)
Outstanding as of December 31, 2024(2)	8,438	$	12.93	3.16 years	$	152
Granted	—	$	—
Exercised	(27)	$	2.64
Forfeited or expired(3)	(363)	$	11.41
Outstanding as of September 30, 2025(2)	8,048	$	13.03	3.46 years	$	516
Exercisable as of September 30, 2025(4)	7,989	$	13.07	3.43 years	$	497
Vested and expected to vest as of September 30, 2025(5)	8,048	$	13.03	3.46 years	$	516

(1)The intrinsic value is the amount by which the current market value of the underlying stock exceeds the exercise price of the stock awards.

(2)Includes 3,539 and 3,620 performance condition stock options as of September 30, 2025 and December 31, 2024, respectively.

(3)Includes 81 performance condition stock options.

(4)Includes 3,539 performance condition stock options.

(5)Includes 3,539 performance condition stock options.

There were no stock options granted during the three and nine months ended September 30, 2025 and 2024. The total intrinsic value of stock options exercised during the three months ended September 30, 2025 and 2024 was $55 and $43, respectively. The total intrinsic value of stock options exercised during the nine months ended September 30, 2025 and 2024 was $56 and $81, respectively.

As of September 30, 2025, the total unrecognized compensation cost related to all nonvested stock options was $320 and the related weighted-average period over which it is expected to be recognized was approximately 1.10 years.

Restricted Stock Units

The following table summarizes the activities for all RSUs under the Company’s stock-based compensation plans for the nine months ended September 30, 2025:


	Number of Shares	Weighted-Average Grant Date Fair Value Per Share
Outstanding as of December 31, 2024(1)	1,902	$	4.94
Granted(2)	1,753	$	3.25
Vested	(563)	$	5.79
Forfeited(3)	(559)	$	5.01
Outstanding as of September 30, 2025(1)	2,533	$	3.57

(1)Includes 323 and 248 performance condition RSUs as of September 30, 2025 and December 31, 2024, respectively.

(2)Includes 323 performance condition RSUs.

(3)Includes 248 performance condition RSUs.

The total vesting date fair value of RSUs which vested during the three months ended September 30, 2025 and 2024 was $223 and $595, respectively. The total vesting date fair value of RSUs which vested during the nine months ended September 30, 2025 and 2024 was $1,343 and $2,056, respectively.

As of September 30, 2025, the total unrecognized compensation cost related to all nonvested RSUs was $6,388 and the related weighted-average period over which it is expected to be recognized was approximately 1.80 years.

Stock-Based Compensation Expense

The following table provides information about stock-based compensation expense by award type:


	Three Months Ended				Nine Months Ended
	September 30, 2025		September 30, 2024		September 30, 2025		September 30, 2024
Stock options	$	208	$	422	$	797	$	1,455
Restricted stock units	1,046		1,405		3,133		3,608
Employee stock purchase plan	389		271		1,166		628
Total stock-based compensation expense	$	1,643	$	2,098	$	5,096	$	5,691

The following table provides information about stock-based compensation expense by financial statement line item:


	Three Months Ended				Nine Months Ended
	September 30, 2025		September 30, 2024		September 30, 2025		September 30, 2024
Cost of revenue (exclusive of depreciation and amortization)	$	—	$	—	$	—	$	(1)
Sales and marketing	280		254		798		699
Research and development	311		438		905		1,066
General and administrative	1,052		1,406		3,393		3,927
Total stock-based compensation expense	$	1,643	$	2,098	$	5,096	$	5,691

Stock-based compensation expense capitalized as part of internal-use software was $42 and $87 for the three months ended September 30, 2025 and 2024, respectively, and $152 and $299 for the nine months ended September 30, 2025 and 2024, respectively.

Veritone, Inc. 10-Q